This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations by Rana Nagarkatti
Introduction
Rana Nagarkatti is a notable inventor based in New Delhi, India. He has made significant contributions to the field of molecular diagnostics through his innovative research and inventions. His work focuses on the genetic analysis of the STAT6 gene, which plays a crucial role in various immunological disorders.
Latest Patents
Rana Nagarkatti holds a patent for "Gene variants of signal transducer and activator of transcription-6 (STAT 6) variants and process of detection the same." This invention relates to allelic variants of the human STAT6 gene and provides primers and methods suitable for detecting these variants. The applications of this invention include molecular diagnosis and predicting an individual's susceptibility to diseases. Specifically, it aids in the detection of predisposition to atopic disorders and other immunological conditions where STAT6 is significant.
Career Highlights
Rana Nagarkatti is associated with the Council of Scientific and Industrial Research, where he has been involved in groundbreaking research. His work has implications for understanding autoimmune disorders, inflammatory disorders, and fibrosis, among others. His innovative approach has garnered attention in the scientific community.
Collaborations
Rana has collaborated with notable colleagues, including Balram Ghosh and Chandrika Rao. Their combined expertise has contributed to advancing research in the field of immunology and genetics.
Conclusion
Rana Nagarkatti's contributions to the field of molecular diagnostics through his patent on STAT6 gene variants highlight the importance of innovation in understanding and diagnosing immunological disorders. His work continues to pave the way for advancements in genetic analysis and disease prediction.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
